Pharmacological study of modified intermediate-dose cytarabine therapy in patients with acute myeloid leukemia

MLA

Hidemasa, Sutoh, et al. “Pharmacological Study of Modified Intermediate-Dose Cytarabine Therapy in Patients with Acute Myeloid Leukemia.” Anticancer Research, vol. 23, no. 6D, Feb. 2004. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........36288bbe3060358bd838e9f4bd9f053e&authtype=sso&custid=ns315887.

APA

Hidemasa, S., Takahiro, Y., Nobuyuki, G., Masatoshi, S., & Takanori, U. (2004). Pharmacological study of modified intermediate-dose cytarabine therapy in patients with acute myeloid leukemia. Anticancer Research, 23(6D).

Chicago

Hidemasa, Sutoh, Yamauchi Takahiro, Gotoh Nobuyuki, Sugiyama Masatoshi, and Ueda Takanori. 2004. “Pharmacological Study of Modified Intermediate-Dose Cytarabine Therapy in Patients with Acute Myeloid Leukemia.” Anticancer Research 23 (6D). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........36288bbe3060358bd838e9f4bd9f053e&authtype=sso&custid=ns315887.